Selskabets formål er direkte og indirekte gennem datterselskaber at udøve forskningsvirksomhed, udvikling, produktion og anden hermed beslægtet aktivitet, fortrinsvis inden for det medicinske og rumteknologiske område samt inden for forsvar og sikkerhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 17.7 mio. | -3.9 mio. | 26.4 mio. | 7.9 mio. | 26 | |
CVR: 12424248
Secondary names: DAMEC RESEARCH A/S, Danish Aerospace Medical Company A/S, Danish Aerospace Company A/S
Previous names: DAMEC RESEARCH A/S, DAMEC RESEARCH ApS, DANISH AEROSPACE COMPANY ApS
Compared to 994 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Tim Sloth Jørgensen joined the board
Steen Michael Lynenskjold joined the board
Søren Bjørn Hansen left the board
Skiftede navn fra DANISH AEROSPACE COMPANY A/S til Danish Aerospace and Defence Company A/S
Fargo ApS registered with 10% ownership
M. GOLDSCHMIDT CAPITAL A/S registered with 20% ownership
Companies in the same industry and area
CVR 35246282
CVR 43729896
CVR 46328159
CVR 61174710
CVR 42002380
The financial health of Danish Aerospace and Defence Company A/S appears to be declining, as evidenced by a significant drop in revenue from 29.7 million DKK in 2023 to 17.7 million DKK in 2024, alongside a shift from profitability to a loss of nearly 3.9 million DKK. Equity has also decreased from 12.1 million DKK to 7.9 million DKK, indicating potential concerns regarding financial stability. The company has experienced fluctuating revenues and profits over the past few years, with a notable peak in 2023. Overall, the declining trend in both revenue and equity raises concerns about its competitive position within the research and development sector.
AI-generated summary
companydata.dk